Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Centre Oscar Lambret
University Hospital Heidelberg
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Baptist Health South Florida
Alliance for Clinical Trials in Oncology
Baptist Health South Florida
Memorial Sloan Kettering Cancer Center
Monteris Medical
Essen Biotech
Essen Biotech
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
Massachusetts General Hospital
NRG Oncology
Hoffmann-La Roche
Ohio State University Comprehensive Cancer Center
Melanoma Institute Australia
Turning Point Therapeutics, Inc.
M.D. Anderson Cancer Center
GT Medical Technologies, Inc.
Hadassah Medical Organization
Emory University
Hellenic Cooperative Oncology Group
Assistance Publique - Hôpitaux de Paris
Plus Therapeutics
University of California, San Francisco
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Henry Ford Health System
MedSIR
NRG Oncology
Grupo Español Multidisciplinar de Melanoma
Thomas Jefferson University
GT Medical Technologies, Inc.
Cedars-Sinai Medical Center
Emory University
Cedars-Sinai Medical Center
BPGbio
Daiichi Sankyo
Actuate Therapeutics Inc.
Wake Forest University Health Sciences
Dynamic Light
Cedars-Sinai Medical Center
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris
Memorial Sloan Kettering Cancer Center
Stanford University
Instituto Nacional de Cancerologia de Mexico